I agree with one point in the Stock Resource report: the whole sale thing has created some uncertainty.
SRK management should be clear that their goal is to develop this baby on their own UNLESS someone offers them the right kind of money.
That should clear up any confusion or misconceptions.
- Forums
- ASX - By Stock
- stock resource report
I agree with one point in the Stock Resource report: the whole...
Featured News
Add SRK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.08M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.0¢ | $5.352K | 173.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9000 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 51602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9000 | 0.032 |
2 | 76666 | 0.030 |
2 | 349158 | 0.028 |
2 | 92965 | 0.027 |
4 | 320371 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 51602 | 1 |
0.039 | 150000 | 1 |
0.040 | 136007 | 1 |
0.042 | 30000 | 1 |
0.048 | 45334 | 1 |
Last trade - 13.33pm 12/11/2024 (20 minute delay) ? |
Featured News
SRK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online